Featured
Stroke Risk Factors Explain Racial Disparities in Stroke Outcomes
Growth Charts Oct 17, 2026
Lunch Nutrition Oct 16, 2026
School Illness Oct 15, 2026
A UCSF study links autoantibodies to preterm birth risk, identifying antibodies that may trigger early...
The immune cell ratio predicts healthy aging and disease risks, offering insights into personalized health...
New research identifies gene signatures linked to severe COVID-19 in children, offering insights into respiratory...
Read our latest Germ Control articles.
Young women face breast cancer diagnosis delays, with lower income linked to later-stage disease, highlighting...
Safety prompts can cut risky AI choices in clinical tests, as researchers found that brief...
The 2026 Nobel Prize in physiology or medicine honors three scientists for an algae study...
AI coding dispute where insurers blame rising costs on AI tools flagging complex diagnoses, while hospitals cite sicker patients.
AI coding dispute where insurers blame rising costs on AI tools flagging complex diagnoses, while hospitals cite sicker patients.
One measles-related death has occurred in the U.S. this year, but the CDC has not disclosed the identity or location...
Addressing social determinants can improve stroke prevention in underserved communities, reducing disparities and saving lives.
Acupuncture may improve Parkinson's disease symptoms, including motor function and quality of life, according to a new study.
Neurologists discuss cluster headache treatments and emerging approaches for chronic cluster headache patients.
New treatments emerge for Alzheimer's agitation, moving beyond off-label drug use with modest benefits.
Denali Therapeutics halted the SAR443820 trial after a phase 2 study failed to slow functional decline in adults with ALS,...
Genetic testing aids epilepsy diagnosis in children with seizures and developmental delays, offering new insights into disease origins.
Expert discusses TDP-43 role in ALS research, a protein present in 97% of ALS patients, to make ALS livable.
Oveporexton shows symptom improvement in narcolepsy type 1, improving wakefulness and quality of life.